Skyrizi Alternatives Compared
| Skyrizi | Taltz | Clobetasol topical |
|
|---|
| Skyrizi (risankizumab) | Taltz (ixekizumab) | Clobetasol topical |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Skyrizi is an interleukin inhibitor that may be used to reduce inflammation-associated plaque psoriasis, psoriatic arthritis, or Crohn's disease in adults. The usual dosage is 150mg every 12 weeks... View more |
Prescription only
Taltz is a monoclonal antibody that reduces inflammation and may be used to treat conditions such as psoriasis, psoriatic arthritis, or ankylosing spondylitis. It is given by injection just under the... View more |
Prescription only
Prescribed for Anal Itching, Cutaneous T-cell Lymphoma, Atopic Dermatitis, Dermatitis, Psoriasis, Dermatological Disorders, Eczema, Lichen Planopilaris, Lichen Planus, Lichen Sclerosus, Necrobiosis... View more |
Related suggestions |
|||||||||||||||
| More about Skyrizi (risankizumab) | More about Taltz (ixekizumab) | More about Clobetasol topical | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Skyrizi has an average rating of 7.2 out of 10 from a total of 29 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 26% reported a negative effect. |
Taltz has an average rating of 7.0 out of 10 from a total of 196 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 24% reported a negative effect. |
Clobetasol topical has an average rating of 8.3 out of 10 from a total of 157 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: Skyrizi side effects in more detail. |
See also: Taltz side effects in more detail. |
See also: clobetasol topical side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Skyrizi prices |
View all Taltz prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Clobevate, Clobex, Clodan, Cormax, Cormax Scalp, Dermovate, Embeline, Embeline E, Impeklo, Impoyz, Olux, Olux-E, Temovate, Temovate Emollient, Tovet View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
672 hours |
312 hours |
N/A |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 162 drugs are known to interact with Skyrizi:
|
A total of 217 drugs are known to interact with Taltz:
|
A total of 47 drugs are known to interact with clobetasol topical:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
April 23, 2019 |
March 22, 2016 |
December 27, 1985 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.